Clinical Trials on Rectocele; Female in New Zealand

Total 3181 results

Spero Therapeutics
United States Department of Defense

Completed

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Renal Impairment

New Zealand
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

IgA Nephropathy

New Zealand
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Recurrent Genital Herpes Simplex Type 2

New Zealand
Escient Pharmaceuticals, Inc
Novotech (Australia) Pty Limited

Completed

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

Pruritus | Cholestasis | Kidney Failure

Australia, New Zealand
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants

Healthy Male Participants

New Zealand
Ionis Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Canada, Australia, New Zealand, Singapore
Murdoch Childrens Research Institute
Royal Children's Hospital

Recruiting

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children (CHOICE UTI)

Infection | Pediatric Infectious Disease | Complicated Urinary Tract Infection

Australia, New Zealand
Omeros Corporation

Recruiting

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

C3 Glomerulopathy | Idiopathic Immune Complex-Mediated Glomerulonephritis

Lithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
InnoCon Medical
Odense University Hospital; Aarhus University Hospital; Herlev Hospital

Completed

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

Urinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders Functional

Denmark
University Health Network, Toronto

Active, not recruiting

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NEO)

Ovarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical Procedures

Canada, United Kingdom, Spain, New Zealand
Pfizer

Completed

PF-04634817 Renal Impairment Study

Renal Insufficiency

United States
Genomic Prediction Inc.

Not yet recruiting

Cell Free Preimplantation Genetic Testing

Infertility, Female | Infertility, Male

United States
Serodus AS

Recruiting

SER150 vs Placebo in Diabetic Kidney Disease

Diabetic Kidney Disease

Australia, New Zealand
Zydus Therapeutics Inc.

Recruiting

A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects With Severe Renal Impairment and Normal Renal Function

Renal Impairment

United States
Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

South Africa, Australia, New Zealand
Olivia Newton-John Cancer Research Institute
Bristol-Myers Squibb

Active, not recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation (MOST-CIRCUIT)

Neuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant Tumor

New Zealand, Australia
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

IgA Nephropathy | C3 Glomerulopathy

New Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
Ra Pharmaceuticals, Inc.

Terminated

Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Australia, Canada, Finland, Germany, Hungary, New Zealand, United Kingdom
Resurge Therapeutics Inc.

Recruiting

RT-310 Dose Escalation BPH Study

Lower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)

New Zealand, Australia
Telix Pharmaceuticals (Innovations) Pty Ltd

Recruiting

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only (PROSTACT)

Metastatic Prostate Cancer

Australia, New Zealand
Hoffmann-La Roche

Completed

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Healthy Male Subjects

Australia, New Zealand
Alexion Pharmaceuticals, Inc.

Terminated

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Italy, Turkey, United Kingdom, New Zealand, Korea, Republic of, Canada, Spain
Vertex Pharmaceuticals Incorporated

Completed

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Pain

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Renal Impairment | Healthy Volunteers

United States
Maimonides Medical Center

Withdrawn

GnRH Agonist at Embryo Transfer: IVF Outcomes (GRAET)

Infertility | Infertility, Female | Infertility, Male

United States
University of New Mexico
University of Pittsburgh; Case Western Reserve University; University of Massachusetts...

Recruiting

Access to Kidney Transplantation in Minority Populations (AKT-MP)

Kidney Diseases

United States
Yale University
United States Department of Defense

Recruiting

AMPK-activation by Metformin in FSGS: AMP-FSGS (AMP-FSGS)

Focal Segmental Glomerulosclerosis

United States
Hoosier Cancer Research Network
University of Sydney; Bionomics Limited; Australia New Zealand Gynaecological...

Withdrawn

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Ovarian Cancer

United States, Australia, New Zealand
GT Urological, LLC

Completed

Clinical Investigation of GT UrologIcal, LLC's Artificial Urinary Sphincter (RELIEF II) (RELIEFII)

Male Stress Urinary Incontinence

Australia, Czechia, New Zealand
Noxopharm Limited

Completed

Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer

Cancer

New Zealand, Georgia, Australia
AstraZeneca
Bristol-Myers Squibb

Completed

Drug Interaction With Metformin

Healthy Male and Female Subjects

United States
ChemoCentryx
Medpace, Inc.

Completed

A Study of CCX140-B in Subjects With FSGS

Focal Segmental Glomerulosclerosis | FSGS | Glomerulosclerosis

United States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
Intuitive Surgical

Completed

A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy

Kidney Cancer

United States
Columbia University

Withdrawn

Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia

Dyspareunia

United States
University of Rochester
Renal Research Institute

Recruiting

Safety, Feasibility, and Tolerability of Sulforaphane in Children With Chronic Kidney Disease

Pediatric Kidney Disease

United States
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment

Ureter Injury

United States
Hackensack Meridian Health

Recruiting

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Urinary Retention

United States
Tulane University

Not yet recruiting

Ultra-Low Contrast Angiography in AKI

Acute Kidney Injury

United States
Big Blue Biotech, Inc.

Terminated

A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care.

Urinary Tract Infections in Children

United States
Natera, Inc.

Active, not recruiting

Renasight Clinical Application, Review and Evaluation (RenaCARE) Study (RenaCARE)

Kidney Diseases

United States
Weill Medical College of Cornell University

Recruiting

Double Voiding and Post-transplant UTI

Urinary Tract Infections | Kidney Transplant; Complications

United States
Far Eastern Memorial Hospital

Recruiting

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

Female Patients With Overactive Bladder Syndrome

Taiwan
University of New Mexico

Completed

Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation (MYPAICE)

Interstitial Cystitis

United States
CSL Behring

Completed

Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD)

United States, Australia, New Zealand, Puerto Rico, Canada, Israel
Hackensack Meridian Health

Recruiting

Post-operative Urinary Retention (POUR) Following Thoracic Surgery (POUR)

Urinary Retention

United States
Overture Life
New Hope Fertility Center

Active, not recruiting

Automated Intracytoplasmic Sperm Injection (ICSIA) (ICSIA)

Infertility, Female

United States
Icahn School of Medicine at Mount Sinai

Not yet recruiting

USCOM in Newly Diagnosed FGR Cases (USCOM FGR)

Fetal Growth Restriction | USCOM

United States
Memorial Sloan Kettering Cancer Center

Completed

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Bladder Cancer

United States
Icahn School of Medicine at Mount Sinai

Completed

Thulium vs. Hol:YAG Laser

Nephrolithiasis

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Drug-Targeted Alerts for Acute Kidney Injury

Acute Kidney Injury

United States

Clinical Trials on Rectocele; Female in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations